As GLP-1 receptor agonists reshape the treatment of diabetes, obesity, and beyond, analytical scientists are being asked to solve increasingly complex problems. This special collection brings together research highlights, expert insight, and practical guidance on how modern measurement science is rising to meet those challenges.
The eBook opens with a research roundup covering recent advances in GLP-1 analysis, from unexpected sources of endogenous GLP-1 to new mass spectrometry workflows for tracking semaglutide and liraglutide in whole blood and detecting counterfeit products.
Elsewhere, Koen Sandra, Amanda Guiraldelli, and Piotr Alvarez of RIC group explore how the rapid commercial success of GLP-1 drugs is driving innovation in peptide design – and creating new analytical challenges around impurity profiling, structural characterization, and lifecycle control. The collection also features an interview with Matthew Lauber (Waters), who shares best practices for analyzing GLP-1 peptides and explains how separation science is evolving to support next-generation therapeutics.
Together, these articles show how analytical science is underpinning the development, regulation, and real-world use of GLP-1 therapies at a time when the field is moving faster than ever.
Click here to download the e-book!
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
